Aethlon Medical annual revenue
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Aethlon Medical Revenue Growth & History (AEMD)
Aethlon Medical reported $0 in revenue for fiscal 2026.
View full Aethlon Medical company overviewAethlon Medical annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $0 | $0 | — |
| 2025 | 2025-03-31 | $0 | $0 | — |
| 2024 | 2024-03-31 | $0 | −$574,245 | −100.00% |
| 2023 | 2023-03-31 | $574,245 | $280,080 | +95.21% |
| 2022 | 2022-03-31 | $294,165 | −$364,939 | −55.37% |
| 2021 | 2021-03-31 | $659,104 | $8,917 | +1.37% |
| 2020 | 2020-03-31 | $650,187 | $420,562 | +183.15% |
| 2019 | 2019-03-31 | $229,625 | $80,000 | +53.47% |
| 2018 | 2018-03-31 | $149,625 | −$242,448 | −61.84% |
| 2017 | 2017-03-31 | $392,073 | −$494,499 | −55.78% |
| 2016 | 2016-03-31 | $886,572 | $124,155 | +16.28% |
| 2015 | 2015-03-31 | $762,417 | −$861,352 | −53.05% |
| 2014 | 2014-03-31 | $1.6M | $393,765 | +32.01% |
| 2013 | 2013-03-31 | $1.2M | −$129,617 | −9.53% |
| 2012 | 2012-03-31 | $1.4M | — | — |
Aethlon Medical quarterly revenue
Q3.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q4 2026 | 2026-03-31 | $0 | $0 | — |
| Q3 2026 | 2025-12-31 | $0 | — | — |
| Q2 2026 | 2025-09-30 | $0 | — | — |
| Q1 2026 | 2025-06-30 | $0 | — | — |
| Q4 2025 | 2025-03-31 | $0 | — | — |
| Q4 2023 | 2023-03-31 | $574,245 | $561,129 | +4278.20% |
| Q3 2023 | 2022-12-31 | $0 | −$17,117 | −100.00% |
| Q2 2023 | 2022-09-30 | $0 | −$131,966 | −100.00% |
| Q1 2023 | 2022-06-30 | $0 | −$131,966 | −100.00% |
| Q4 2022 | 2022-03-31 | $13,116 | −$21,117 | −61.69% |
| Q3 2022 | 2021-12-31 | $17,117 | −$607,754 | −97.26% |
| Q2 2022 | 2021-09-30 | $131,966 | $131,966 | — |
| Q1 2022 | 2021-06-30 | $131,966 | $131,966 | — |
| Q4 2021 | 2021-03-31 | $34,233 | −$172,496 | −83.44% |
| Q3 2021 | 2020-12-31 | $624,871 | $211,413 | +51.13% |
| Q2 2021 | 2020-09-30 | $0 | $0 | — |
| Q1 2021 | 2020-06-30 | $0 | −$30,000 | −100.00% |
| Q4 2020 | 2020-03-31 | $206,729 | $126,729 | +158.41% |
| Q3 2020 | 2019-12-31 | $413,458 | $413,458 | — |
| Q2 2020 | 2019-09-30 | $0 | $0 | — |
| Q1 2020 | 2019-06-30 | $30,000 | −$119,625 | −79.95% |
| Q4 2019 | 2019-03-31 | $80,000 | $5,188 | +6.93% |
| Q3 2019 | 2018-12-31 | $0 | −$74,813 | −100.00% |
| Q2 2019 | 2018-09-30 | $0 | $0 | — |
| Q1 2019 | 2018-06-30 | $149,625 | $149,625 | — |
| Q4 2018 | 2018-03-31 | $74,812 | $74,812 | — |
| Q3 2018 | 2017-12-31 | $74,813 | $74,813 | — |
| Q2 2018 | 2017-09-30 | $0 | −$387,438 | −100.00% |
| Q1 2018 | 2017-06-30 | $0 | −$4,635 | −100.00% |
| Q4 2017 | 2017-03-31 | $0 | −$204,665 | −100.00% |
| Q3 2017 | 2016-12-31 | $0 | −$301,033 | −100.00% |
| Q2 2017 | 2016-09-30 | $387,438 | $199,072 | +105.68% |
| Q1 2017 | 2016-06-30 | $4,635 | −$187,873 | −97.59% |
| Q4 2016 | 2016-03-31 | $204,665 | $6,053 | +3.05% |
| Q3 2016 | 2015-12-31 | $301,033 | $267,599 | +800.38% |
| Q2 2016 | 2015-09-30 | $188,366 | −$290,709 | −60.68% |
| Q1 2016 | 2015-06-30 | $192,508 | $141,212 | +275.29% |
| Q4 2015 | 2015-03-31 | $198,612 | −$508,361 | −71.91% |
| Q3 2015 | 2014-12-31 | $33,434 | −$42,879 | −56.19% |
| Q2 2015 | 2014-09-30 | $479,075 | −$165,812 | −25.71% |
| Q1 2015 | 2014-06-30 | $51,296 | −$144,300 | −73.77% |
| Q4 2014 | 2014-03-31 | $706,973 | $302,611 | +74.84% |
| Q3 2014 | 2013-12-31 | $76,313 | −$132,468 | −63.45% |
| Q2 2014 | 2013-09-30 | $644,887 | $244,773 | +61.18% |
| Q1 2014 | 2013-06-30 | $195,596 | −$21,151 | −9.76% |
| Q4 2013 | 2013-03-31 | $404,362 | — | — |
| Q3 2013 | 2012-12-31 | $208,781 | −$749,294 | −78.21% |
| Q2 2013 | 2012-09-30 | $400,114 | — | — |
| Q1 2013 | 2012-06-30 | $216,747 | — | — |
| Q3 2012 | 2011-12-31 | $958,075 | — | — |
Aethlon Medical revenue growth trends
Aethlon Medical's latest reported quarter, Q4 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Aethlon Medical source filings ↗Community posts
Aethlon agrees to North Immunology merger backed by $180 million financing
Aethlon ($AEMD) Medical agreed to an all-stock merger with North Immunology, accompanied by a private placement described as approximately $180 million in gross proceeds. That amount includes the conversion of roughly $34 million of existin ...
